Literature DB >> 11572029

Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D'etude des Néoplasies Endocriniennes Multiples Study Group.

P Goudet1, P Cougard, B Vergès, A Murat, B Carnaille, A Calender, J Faivre, C Proye.   

Abstract

The French and Belgian GENEM study group's multiple endocrine neoplasia type I (MEN-I) database was used to evaluate trends in clinical presentation, surgical treatment of primary hyperparathyroidism (pHPT) (n = 245), and prognostic factors for hypercalcemia correction among 256 MEN-I cases. The patients were retrieved through the GENEM network from various Belgian and French institutions with the help of genetics laboratories. Among the 245 pHPT patients (96%), 42% were men. The mean age at the time of diagnosis was 39.5 +/- 13.3 years. Trends were studied for three periods: before 1986, from 1986 to 1990, and thereafter. After 1990 MEN-I patients were more often diagnosed with isolated pHPT (8%, 11%, 28%, for the three periods, respectively; p = 0.002); it was seen more often in screened patients (31%, 28%, 53%; p = 0.001), more often among those in already known MEN-I families (64%, 45%, 72%; p = 0.005), and among those with lower preoperative calcemia (2.93, 2.87, 2.79 mmol/L; p = 0.001). The age at pHPT diagnosis remained constant throughout the study. The percentage of cervical explorations dropped during the entire study (87%, 87%, 53%; p < 0.0001). After 1985 the percentage of subtotal parathyroidectomies increased (25%, 59%, 51%; p = 0.0004). Pathology disclosed more hyperplasias (59%, 85%, 74%; p = 0.008). Postoperative hypercalcemia decreased (47%, 15%, 19%; p < 0.0001); and postoperative hypocalcemia increased nonsignificantly (5%, 15%, 15%; p = 0.1). Subtotal parathyroidectomy [odds ratio (OR) 13], no MEN-I family background (OR 3), and the most recent study period (> 1985) (OR 3) were significant predictive factors of hypercalcemia correction according to the multivariate analysis. This is the first multicentric study on the management of MEN-I-related pHPT. Immediate postoperative hHPT cure increased, but only 80% of the operated patients were cured after 1990. Fifteen percent were hypocalcemic. Because MEN-I-related hHPT cure remains difficult to achieve, we advocate that subtotal parathyroidectomies be performed in specialized centers.

Entities:  

Mesh:

Year:  2001        PMID: 11572029     DOI: 10.1007/s00268-001-0046-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  15 in total

1.  A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors.

Authors:  B T Teh; C T Esapa; R Houlston; U Grandell; F Farnebo; M Nordenskjöld; C J Pearce; D Carmichael; C Larsson; P E Harris
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

2.  Positional cloning of the gene for multiple endocrine neoplasia-type 1.

Authors:  S C Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; F S Collins; M R Emmert-Buck; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; J S Crabtree; Y Wang; B A Roe; J Weisemann; M S Boguski; S K Agarwal; M B Kester; Y S Kim; C Heppner; Q Dong; A M Spiegel; A L Burns; S J Marx
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

3.  Mitogenic activity on parathyroid cells in plasma from members of a large kindred with multiple endocrine neoplasia type 1.

Authors:  S J Marx; K Sakaguchi; J Green; G D Aurbach; M L Brandi
Journal:  J Clin Endocrinol Metab       Date:  1988-07       Impact factor: 5.958

4.  The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized?

Authors:  J J Shepherd
Journal:  Arch Surg       Date:  1991-08

5.  Somatic mutation of the MEN1 gene in parathyroid tumours.

Authors:  C Heppner; M B Kester; S K Agarwal; L V Debelenko; M R Emmert-Buck; S C Guru; P Manickam; S E Olufemi; M C Skarulis; J L Doppman; R H Alexander; Y S Kim; S K Saggar; I A Lubensky; Z Zhuang; L A Liotta; S C Chandrasekharappa; F S Collins; A M Spiegel; A L Burns; S J Marx
Journal:  Nat Genet       Date:  1997-08       Impact factor: 38.330

6.  Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1.

Authors:  P Hellman; B Skogseid; C Juhlin; G Akerström; J Rastad
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

7.  Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.

Authors:  S Giraud; C X Zhang; O Serova-Sinilnikova; V Wautot; J Salandre; N Buisson; C Waterlot; C Bauters; N Porchet; J P Aubert; P Emy; G Cadiot; B Delemer; O Chabre; P Niccoli; F Leprat; F Duron; B Emperauger; P Cougard; P Goudet; E Sarfati; J P Riou; S Guichard; M Rodier; A Meyrier; P Caron; M C Vantyghem; M Assayag; J L Peix; M Pugeat; V Rohmer; M Vallotton; G Lenoir; P Gaudray; C Proye; B Conte-Devolx; P Chanson; Y Y Shugart; D Goldgar; A Murat; A Calender
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

8.  Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1.

Authors:  L Benson; S Ljunghall; G Akerström; K Oberg
Journal:  Am J Med       Date:  1987-04       Impact factor: 4.965

9.  Gastric secretion and hormonal interactions in multiple endocrine neoplasia type I.

Authors:  H K Gogel; M T Buckman; D Cadieux; D M McCarthy
Journal:  Arch Intern Med       Date:  1985-05

10.  Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study.

Authors:  J A Norton; M J Cornelius; J L Doppman; P N Maton; J D Gardner; R T Jensen
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

View more
  21 in total

Review 1.  Clinical aspects of multiple endocrine neoplasia type 1.

Authors:  Abdallah Al-Salameh; Guillaume Cadiot; Alain Calender; Pierre Goudet; Philippe Chanson
Journal:  Nat Rev Endocrinol       Date:  2021-02-09       Impact factor: 43.330

2.  Causes and treatment of recurrent hyperparathyroidism after subtotal parathyroidectomy in the presence of multiple endocrine neoplasia 1.

Authors:  Maria D Balsalobre Salmeron; Jose Manuel Rodriguez Gonzalez; Joan Sancho Insenser; Joan Sancho Fornos; Albert Goday; Nuria Maria Torregrosa Perez; Antonio Rios Zambudio; Pascual Parrilla Paricio; Antonio Sitges Serra
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 3.  The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review.

Authors:  Jennifer M J Schreinemakers; Carolina R C Pieterman; Anouk Scholten; Menno R Vriens; Gerlof D Valk; Inne H M Borel Rinkes
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

4.  Multiple endocrine neoplasia type 1 parathyroid adenoma development over time.

Authors:  Gerard M Doherty; Terry C Lairmore; Mary K DeBenedetti
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

5.  Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).

Authors:  Pierre Goudet; Arnaud Murat; Catherine Cardot-Bauters; Philippe Emy; Eric Baudin; Hélène du Boullay Choplin; Yves Chapuis; Jean-Louis Kraimps; Jean-Louis Sadoul; Antoine Tabarin; Bruno Vergès; Bruno Carnaille; Patricia Niccoli-Sire; Annie Costa; Alain Calender
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

Review 6.  Familial parathyroid tumors: diagnosis and management.

Authors:  Peter Stålberg; Tobias Carling
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

7.  The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism.

Authors:  Anathea C Powell; H Richard Alexander; James F Pingpank; Seth M Steinberg; Monica Skarulis; David L Bartlett; Sunita Agarwal; Craig Cochran; Geoffrey Seidel; Douglas Fraker; Marybeth S Hughes; Robert T Jensen; Stephen J Marx; Steven K Libutti
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

8.  Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.

Authors:  Jeffrey A Norton; David J Venzon; Marc J Berna; H R Alexander; Douglas L Fraker; Stephen K Libutti; Stephen J Marx; Fathia Gibril; Robert T Jensen
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

Review 9.  Hereditary hyperparathyroidism--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Maurizio Iacobone; Bruno Carnaille; F Fausto Palazzo; Menno Vriens
Journal:  Langenbecks Arch Surg       Date:  2015-10-08       Impact factor: 3.445

10.  Long-Term Surveillance of Treated Hyperparathyroidism for Multiple Endocrine Neoplasia Type 1: Recurrence or Hypoparathyroidism?

Authors:  Ellen Fyrsten; Olov Norlén; Ola Hessman; Peter Stålberg; Per Hellman
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.